Id |
Subject |
Object |
Predicate |
Lexical cue |
T278 |
0-6 |
Sentence |
denotes |
2.3.1. |
T279 |
7-27 |
Sentence |
denotes |
Rheumatoid Arthritis |
T280 |
28-146 |
Sentence |
denotes |
Rheumatoid arthritis is a systemic autoimmune disease, characterized by chronic inflammation and damage to the joints. |
T281 |
147-377 |
Sentence |
denotes |
Immune dysregulation underlies the pathogenesis of rheumatoid arthritis, leading to uncontrolled production of antibodies, mainly rheumatoid factor and citrullinate, involved in the autoreactivity against cartilage and bone [117]. |
T282 |
378-474 |
Sentence |
denotes |
It is estimated that the prevalence of rheumatoid arthritis is around 1%, mainly in women [118]. |
T283 |
475-650 |
Sentence |
denotes |
The immunosuppressive effects of HCQ are due to the ability to modulate T-cell and B-cell hyperactivity, resulting in a reduction of pro-inflammatory cytokine gene expression. |
T284 |
651-887 |
Sentence |
denotes |
As the involvement of neutrophils in this disease, Jancinova, Pazourekova, Lucova, Perecko, Mihalova, Bauerova, Nosal and Drabikova [75] investigated the impact of oral HCQ administration on these cells, in rats with adjuvant arthritis. |
T285 |
888-1099 |
Sentence |
denotes |
At doses of 40 mg/kg daily, per oral administration (p.o.), it strongly decreased the blood concentration of neutrophil-derived oxidants, involved in the tissue damage and the onset of chronic inflammation [75]. |
T286 |
1100-1309 |
Sentence |
denotes |
A 36-week randomized, double-blind, placebo-controlled trial has evaluated the effect of the administration of HCQ in a dose of up to 7 mg/kg per day (maximum 400 mg/day) in patients with rheumatoid arthritis. |
T287 |
1310-1501 |
Sentence |
denotes |
Within 36 weeks and during the study, HCQ showed statistically significant benefits on physical function, mainly on synovitis and joint pain, without side effects with respect to the control. |
T288 |
1502-1577 |
Sentence |
denotes |
Moreover, HCQ was associated with a decrement of corticosteroid injections. |
T289 |
1578-1661 |
Sentence |
denotes |
By contrast, no improvements in psychological function have been demonstrated [76]. |
T290 |
1662-1912 |
Sentence |
denotes |
Two comparative double-blind, randomized trials, involving 60 patients each, with sulfasalazine and HCQ have demonstrated that HCQ showed no significant differences among overall clinical effects respect to sulfasalazine, but presented a later onset. |
T291 |
1913-2343 |
Sentence |
denotes |
In the first study, patients treated with HCQ (400 mg/day for 6 months and 200 mg/day for the next 6 months) experienced time-dependent statistically significant improvements in morning stiffness, pain, swollen joints, together with a decrease in blood levels of immunoglobulin M and erythrocyte sedimentation rate [77], while, in the second study, the same treatment was associated to no erosions in the 12% of the patients [78]. |
T292 |
2344-2464 |
Sentence |
denotes |
In patients with rheumatoid arthritis, the cardiovascular risk is more than doubled, compared to the healthy population. |
T293 |
2465-2639 |
Sentence |
denotes |
Chronic inflammatory status leads to an intensification of the atherosclerotic process, resulting in a higher susceptibility to hypertension, obesity, and metabolic syndrome. |
T294 |
2640-2760 |
Sentence |
denotes |
The overproduction of IL-6 is strictly related to lipid profile alterations, given its role in adipose tissue lipolysis. |
T295 |
2761-2838 |
Sentence |
denotes |
The inflammation and endothelial damage are exacerbated by leptin production. |
T296 |
2839-2976 |
Sentence |
denotes |
Batun-Garrido, Salas-Magana and Juarez-Rojop [79] found a significant correlation between HCQ treatment and lower IL-6 and leptin levels. |
T297 |
2977-3342 |
Sentence |
denotes |
The positive effect of HCQ on dyslipidemia was also confirmed by Morris, Wasko, Antohe, Sartorius, Kirchner, Dancea and Bili [80] in a cohort study involving 706 rheumatoid arthritis diagnosed patients, finding a significant and stable cholesterol-lowering, mainly Low-Density Lipoprotein (LDL), and triglyceride decrease associated with HCQ intake (6.5 mg/kg/day). |
T298 |
3343-3573 |
Sentence |
denotes |
A small but statistically significant amelioration in total cholesterol and LDL under HCQ treatment at the same dosage was also highlighted by a randomized, double-blind cross-over trial on patients with rheumatoid arthritis [81]. |
T299 |
3574-3731 |
Sentence |
denotes |
The correlation between HCQ and cardiovascular risk was also assessed in a cross-sectional observational study involving 177 women with rheumatoid arthritis. |
T300 |
3732-3868 |
Sentence |
denotes |
At doses of 200 mg/kg/day, HCQ usage led to lower fasting glucose in women, arising as a valuable tool to enhance glycemic control [82]. |
T301 |
3869-4084 |
Sentence |
denotes |
However, apparent different outcomes were derived from a randomized double-blind crossover trial, recruiting 23 non-diabetic subjects with stable rheumatoid arthritis to receive 6.5 mg/kg/day of HCQ for eight weeks. |
T302 |
4085-4171 |
Sentence |
denotes |
For these patients, no significant changes in insulin resistance were observable [81]. |
T303 |
4172-4304 |
Sentence |
denotes |
This study evaluated only insulin sensitivity, by Homeostatic Model Assessment (HOMA) index, without considering insulin metabolism. |
T304 |
4305-4407 |
Sentence |
denotes |
Thus, inconsistency should be explained by this factor, together with the short duration of treatment. |
T305 |
4408-4534 |
Sentence |
denotes |
The anti-diabetic properties of HCQ have been also assessed in patients without arthritis, as reported in the next paragraphs. |